Abstract
AimTo predict antivascular endothelial growth factor (VEGF) treatment requirements, visual acuity and morphological outcomes in neovascular age-related macular degeneration (nAMD) using fluid quantification by artificial intelligence (AI) in a real-world...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have